Abacus Planning Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $439K | Sell |
2,367
-153
| -6% | -$28.4K | 0.07% | 138 |
|
|
2025
Q1 | $528K | Buy |
2,520
+364
| +17% | +$76.3K | 0.09% | 110 |
|
|
2024
Q4 | $383K | Sell |
2,156
-56
| -3% | -$9.95K | 0.07% | 137 |
|
|
2024
Q3 | $437K | Buy |
2,212
+743
| +51% | +$147K | 0.08% | 124 |
|
|
2024
Q2 | $252K | Buy |
1,469
+61
| +4% | +$10.5K | 0.05% | 181 |
|
|
2024
Q1 | $256K | Sell |
1,408
-474
| -25% | -$86.3K | 0.05% | 173 |
|
|
2023
Q4 | $292K | Buy |
+1,882
| New | +$292K | 0.06% | 149 |
|
|
2023
Q3 | – | Sell |
-1,592
| Closed | -$214K | – | 190 |
|
|
2023
Q2 | $214K | Sell |
1,592
-88
| -5% | -$11.9K | 0.05% | 178 |
|
|
2023
Q1 | $268K | Buy |
1,680
+188
| +13% | +$30K | 0.07% | 144 |
|
|
2022
Q4 | $241K | Buy |
+1,492
| New | +$241K | 0.07% | 152 |
|
|
2022
Q3 | – | Sell |
-1,764
| Closed | -$270K | – | 179 |
|
|
2022
Q2 | $270K | Sell |
1,764
-197
| -10% | -$30.2K | 0.08% | 143 |
|
|
2022
Q1 | $318K | Buy |
1,961
+302
| +18% | +$49K | 0.09% | 146 |
|
|
2021
Q4 | $225K | Buy |
+1,659
| New | +$225K | 0.06% | 181 |
|